MPM.B. Pushkar

M.B. Pushkar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


M.B. Pushkar has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Generalized non-erythematous form of systemic tick-borne borreliosis: diagnostic difficulties (clinical case)

    by V.A. Mishchenko, I.YU. Odynets, M.B. Pushkar, O.M. Olkhovska, R.M. Hrynov, M.O. Zhelieznikova, V.A. Maloshtan

    Non-erythematous forms of systemic tick-borne borreliosis, or Lyme disease (LD), are considered one of the most difficult to diagnose due to the lack of a pathognomonic (specific) marker of the disease — erythema migrans. In such a situation, the clinician should take into account the season, the patient’s residence or stay in a region endemic for LD, the possibility of an alimentary route of infection with Borrelia when consuming dairy products from sick domestic animals. The non-erythematous form of LD often proceeds as a common acute respiratory viral infection or flu and begins with the appearance of fever, weakness, headache, pain in muscles and joints. Sometimes the disease is masked as other pathologies: myocarditis, chorioretinitis, neurological disorders (facial nerve palsy, radiculopathy, meningoencephalitis), hepatitis. The appearance in a patient in a region endemic for tick activity of any symptoms without erythema migrans requires examination for LD, if these symptoms are not explained by other nosological forms. In order to identify specific antibody titers and assess their dynamics, serological blood testing is prescribed by the enzyme-linked immunosorbent assay, with a repeat after 2–4 weeks. The study of cerebrospinal fluid by polymerase chain reaction for the presence of Borrelia is diagnostically significant in cases of meningoencephalitis. Underestimation of the above-mentioned clinical and anamnestic data and laboratory criteria leads to diagnostic errors, delayed treatment and significantly increases the risk of developing chronic forms of the disease and complications.

  • Open Access

    A clinical case of extrabuccal scarlet fever caused by Streptococcus pyogenes in a serviceman

    by E.M. Khoroshun, V.A. Mishchenko, K.I. Bodnia, V.V. Nehoduiko, M.B. Pushkar, O.V. Nerusheva, V.V. Kondratyuk

    In this case, the wound streptococcal infection caused by Streptococcus pyogenes in a serviceman became generalized, which gave reason to clinically diagnose extrabuccal scarlet fever and confirm this diagnosis based on laboratory examination. Today, doctors are not sufficiently aware of the diagnosis and treatment of extrabuccal scarlet fever, cases of which were practically not registered in peacetime, but became significantly more frequent during the period of military operations. Timely administration of antibacterial therapy and wound treatment, taking into account the risk of secondary streptococcal infection in shrapnel wounds and skin burns, is advisable at the pre-hospital stage.

  • Open Access

    A clinical case of a generalized infection caused by Yersinia enterocolitica in a serviceman

    by E.M. Khoroshun, K.I. Bodnia, V.A. Mishchenko, V.V. Nehoduiko, V.V. Kondratyuk, V.V. Pavliy, M.B. Pushkar

    Yersiniosis is a disease that can mimic the clinical picture of other diseases: acute respiratory viral infections, scarlet fever, intestinal infection, appendicitis, sepsis, rheumatism, mononucleosis, etc. This leads to diagnostic errors and requires considering the possibility of contamination of food and water with rodent excrement in places of deployment of personnel in wartime conditions. In this case, the infection caused by Yersinia enterocolitica in a serviceman was not detected in a timely manner and acquired a generalized course. Timely diagnosis and prescription of antibacterial therapy at the prehospital stage will contribute to the rapid recovery of servicemen and the avoidance of undesirable complications of the disease.

  • Open Access

    The role of aztreonam in rational antibacterial therapy of resistant nosocomial gram-negative infections. The new life for a well-known β-lactam

    by V.A. Korsunov, M.A. Georgiyants, N.I. Zozulia, I.YU. Odynets, M.B. Pushkar, M.V. Lyzogub, N.M. Bohuslavska, O.L. Onikiienko

    Background. The situation regarding the prevalence of resistant pathogens, types of β-lactamase products, and, accordingly, the justification of rational approaches to antibacterial therapy in Ukraine remains insufficiently studied. Objective: based on the determination of the etiological structure of the causative agents of hospital infections in the Kharkiv region and the state of their resistance due to the production of β-lactamases, to propose rational approaches to antibacterial therapy and assess the feasibility of using aztreonam as a potentially effective mean of treating infections caused by resistant bacteria. Materials and methods. In 251 patients, samples of biomaterials were tested by the polymerase chain reaction for the presence of the following gram-negative pathogens: P.aeruginosa, Enterobacter, E.coli, K.pneumoniae, Proteus spp. and A.baumanii. A molecular genetic study was also conducted to identify certain types of β-lactamases. Results. In the structure of hospital pathogens, the absolute majority of gram-negative bacteria belong to the enterobacteria family. When determining the profile of β-lactamases, we found that in 59.38 % of cases, E.coli was able to produce metallo-β-lactamases, which makes the therapy with carbapenems or ceftazidime-avibactam impossible. An alternative in such cases is a combination of aztreonam and ceftazidime-avibactam. When the causative agent K.pneumoniae is detected, in some cases there may also be a need for combined therapy with the use of aztreonam. It was found that Enterobacter spp. in most cases is sensitive to carbapenems. A.baumanii is completely insensitive to carbapenems and requires alternative approaches to antibacterial therapy, including aztreonam, ceftazidime-avibactam, and polymyxins. P.aeruginosa was found only as part of polymicrobial associations, so it was impossible to analyze its β-lactamase production profile. Conclusions. The results of the conducted study demonstrate an extremely high detection of gram-negative antibiotic-resistant pathogens in patients of the intensive care units in the Kharkiv region. Microorganisms such as E.coli and A.baumanii have the most unfavorable profile of antibiotic resistance, which is due to the high frequency of production of serine carbapenemases and metallo-β-lactamases, whose presence makes the effective use of carbapenems impossible.

  • Open Access

    Внутрішньовенна неопіоїдна аналгезія як компонент періопераційного знеболювання: літературний огляд використання ібупрофену для внутрішньовенного застосування

    by M.A. Georgiyants, V.A. Korsunov, M.B. Pushkar

    Розвиток анестезіології на початку ХХІ століття характеризується тенденцією до обмеження використання опіоїдів під час як анестезії (низькоопіоїдна та безопіоїдна анестезія), так і післяопераційного знеболювання (мультимодальне знеболювання). Одним із найбільш поширених напрямків зменшення споживання опіоїдів є використання нестероїдних протизапальних засобів. Застосування внутрішньовенної форми добре відомого представника цієї групи препаратів — ібупрофену відкриває нові можливості лікування болю в різних галузях хірургії, анестезіології та інтенсивної терапії. Низка досліджень, результати яких проаналізовані в даному літературному огляді, ґрунтовно доводить, що використання ібупрофену в дозі 800 мг внутрішньовенно дозволяє забезпечити краще післяопераційне знеболювання та зменшення потреби в опіоїдних анальгетиках порівняно з плацебо та таким компаратором, як ацетамінофен. Також ібупрофен для внутрішньовенного введення продемонстрував кращі антипіретичні властивості порівняно з ацетамінофеном при лікуванні лихоманки в госпіталізованих пацієнтів дитячого віку.